Max Robotics — Global Service Robot Directory + US Certification

About

Elliot Newman is a surgical oncologist whose research centers on advancing minimally invasive techniques in pancreatic surgery, with a particular focus on robotic approaches. His work addresses one of the most challenging areas in gastrointestinal oncology: improving outcomes for patients undergoing complex pancreatic resections. Newman’s most cited study, a multi-institutional matched comparison of robotic versus open distal pancreatectomy (26 citations), demonstrated that robotic surgery can achieve comparable oncologic outcomes while potentially reducing postoperative complications, particularly clinically relevant pancreatic fistulas. He has also pioneered the application of robotic surgery for rare conditions, as shown in his work on ectopic pancreas management (15 citations), helping define which symptomatic patients benefit from minimally invasive resection. More recently, Newman analyzed national ACS-NSQIP data (7 citations) to compare minimally invasive and open pancreatoduodenectomies for pancreatic adenocarcinoma, contributing critical evidence to the ongoing debate about the safety and efficacy of these approaches. His research directly informs surgical decision-making, balancing the technical demands of pancreatic surgery with the goal of minimizing morbidity in high-risk patients.